Evidence map›Paper›PMID 33830085›Full record

ArticleJCI insight2021

Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung.

Sheng Xia, Heather L Menden, Nick Townley, Sherry M Mabry, Jeffrey Johnston, Michael F Nyp, Daniel P Heruth, Thomas Korfhagen, Venkatesh Sampath

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Physiological Modeling of the Vascularized Human Lung Organoid.American journal of respiratory cell and molecular biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Lung epithelium development and airway regeneration.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sheng XiaDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Heather L MendenDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Nick TownleyDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Sherry M MabryDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Jeffrey JohnstonGenomic Medicine Center, Children's Mercy Hospital, Kansas City, Missouri, USA.
Michael F NypDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Daniel P HeruthDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Thomas KorfhagenDivision of Neonatology, Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Venkatesh SampathDivision of Neonatology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Children's Mercy Hospital · USCincinnati Children's Hospital Medical Center · US

Funding

Inflammatory Angiogenesis in the LungR01HL128374 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI SAMPATH, VENKATESH · 2015 to 2020
$1.8M
NHLBI NIH HHS R01 HL128374
6 · The paper itself

Abstract

The molecular mechanisms by which endothelial cells (ECs) regulate pulmonary vascularization and contribute to alveolar epithelial cell development during lung morphogenesis remain unknown. We tested the hypothesis that delta-like 4 (DLL4), an EC Notch ligand, is critical for alveolarization by combining lung mapping and functional studies in human tissue and DLL4-haploinsufficient mice (Dll4+/lacz). DLL4 expressed in a PECAM-restricted manner in capillaries, arteries, and the alveolar septum from the canalicular to alveolar stage in mice and humans. Dll4 haploinsufficiency resulted in exuberant, nondirectional vascular patterning at E17.5 and P6, followed by smaller capillaries and fewer intermediate blood vessels at P14. Vascular defects coincided with polarization of lung EC expression toward JAG1-NICD-HES1 signature and decreased tip cell-like (Car4) markers. Dll4+/lacZ mice had impaired terminal bronchiole development at the canalicular stage and impaired alveolarization upon lung maturity. We discovered that alveolar type I cell (Aqp5) markers progressively decreased in Dll4+/lacZ mice after birth. Moreover, in human lung EC, DLL4 deficiency programmed a hypersprouting angiogenic phenotype cell autonomously. In conclusion, DLL4 is expressed from the canalicular to alveolar stage in mice and humans, and Dll4 haploinsufficiency programs dysmorphic microvascularization, impairing alveolarization. Our study reveals an obligate role for DLL4-regulated angiogenesis in distal lung morphogenesis.

Indexed as

Adaptor Proteins, Signal TransducingAlveolar Epithelial CellsAnimalsCalcium-Binding ProteinsGene Expression Regulation, DevelopmentalHaploinsufficiencyHumansHypoxiaLungMiceMice, Inbred C57BLMice, Mutant StrainsNeovascularization, PhysiologicPulmonary AlveoliAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDLL4 protein, humanDLL4 protein, mouseEndothelial cellsMolecular biologyPulmonologyVascular Biology

Identifiers

PMID33830085
PMCPMC8119184
OpenAlexW3143166719

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.